Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.82 |
| ▸ | MEN1 | O00255 | 8/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.76 |
| ▸ | NPC1 | O15118 | 1/20 | 0.76 |
| ▸ | RAB9A | P51151 | 1/20 | 0.76 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.68 |
| ▸ | MAPT | P10636 | 3/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.67 |
| ▸ | POLB | P06746 | 3/20 | 0.67 |
| ▸ | DDX3X | O00571 | 1/20 | 0.67 |
| ▸ | HTT | P42858 | 1/20 | 0.67 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.67 |
| ▸ | GAA | P10253 | 1/20 | 0.62 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.61 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26496469 | 1.00 | L3MBTL1 (0.82) | L3MBTL1MEN1KMT2ANPC1RAB9A | |
| SCHEMBL15480402 | 0.94 | L3MBTL1 (0.74) | L3MBTL1MEN1KMT2ANPC1RAB9A | |
| SCHEMBL30555757 | 0.93 | MEN1 (0.72) | L3MBTL1MEN1KMT2ANPC1RAB9A | |
| SCHEMBL9167675 | 0.93 | MEN1 (0.72) | L3MBTL1MEN1KMT2ANPC1RAB9A | |
| SCHEMBL30020550 | 0.93 | MEN1 (0.72) | L3MBTL1MEN1KMT2ANPC1RAB9A | |
| SCHEMBL8585803 | 0.91 | L3MBTL1 (0.69) | L3MBTL1MEN1KMT2ANPC1RAB9A | |
| SCHEMBL8613820 | 0.91 | L3MBTL1 (0.69) | L3MBTL1MEN1KMT2ANPC1RAB9A | |
| SCHEMBL4749309 | 0.90 | L3MBTL1 (0.76) | L3MBTL1MEN1KMT2ANPC1RAB9A | |
| SCHEMBL7825577 | 0.90 | L3MBTL1 (1.00) | L3MBTL1MEN1KMT2ANPC1RAB9A | |
| SCHEMBL11756426 | 0.90 | MEN1 (0.80) | L3MBTL1MEN1KMT2ANPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260022092-A1 | PROCESS FOR SOLVENT FREE CONTINUOUS SYNTHESIS OF AMIDES AND PEPTIDES | COUNCIL SCIENT IND RES (IN) | 2026-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022092-A1 | PROCESS FOR SOLVENT FREE CONTINUOUS SYNTHESIS OF AMIDES AND PEPTIDES | TNF, VIP, APP | L3MBTL1 3868/4885MEN1 3144/4885KMT2A 1663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.